EXJADE 125 MG Israel - English - Ministry of Health

exjade 125 mg

novartis israel ltd - deferasirox - tablets dispersible - deferasirox 125 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).lic is the preferred method of iron overload determination and should be used wherever available

EXJADE 500 MG Israel - English - Ministry of Health

exjade 500 mg

novartis israel ltd - deferasirox - tablets dispersible - deferasirox 500 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).lic is the preferred method of iron overload determination and should be used wherever available

EXJADE 250 MG Israel - English - Ministry of Health

exjade 250 mg

novartis israel ltd - deferasirox - tablets dispersible - deferasirox 250 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).lic is the preferred method of iron overload determination and should be used wherever available

MICROGYNON  30 Israel - English - Ministry of Health

microgynon 30

bayer israel ltd - ethinylestradiol; levonorgestrel - coated tablets - levonorgestrel 150 mcg; ethinylestradiol 30 mcg - progestogens and estrogens, fixed combinations - oral contraceptive.

MENOGON Israel - English - Ministry of Health

menogon

ferring pharmaceuticals ltd - follicle stimulating hormone (fsh); luteinizing hormone - powder and solvent for solution for injection - follicle stimulating hormone (fsh) 75 iu/vial; luteinizing hormone 75 iu/vial - gonadotropins - sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism.

REMOTIV 250 Israel - English - Ministry of Health

remotiv 250

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 250 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions. treatment is recommended for up to 24 weeks.

TYKERB Israel - English - Ministry of Health

tykerb

novartis israel ltd - lapatinib as ditosylate monohydrate - film coated tablets - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting .• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

REMOTIV 500 Israel - English - Ministry of Health

remotiv 500

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 500 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions.treatment is recommended for up to 24 weeks.

Evra European Union - English - EMA (European Medicines Agency)

evra

gedeon richter plc. - norelgestromin, ethinyl estradiol - contraception - sex hormones and modulators of the genital system, - female contraception.evra is intended for women of fertile age. the safety and efficacy has been established in women aged 18 to 45 years.

Exviera European Union - English - EMA (European Medicines Agency)

exviera

abbvie ltd - dasabuvir sodium - hepatitis c, chronic - antivirals for systemic use, - exviera is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults. for hepatitis c virus (hcv) genotype specific activity.,